Pending Case

Mallinckrodt plc

Nasdaq: MNK

Mallinckrodt (MNK) Investigated by Block & Leviton LLP For Violations of Federal Securities Laws

Contact us to learn more about this lawsuit.

Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether Mallinckrodt plc ("Mallinckrodt" or the "Company") (NYSE: MNK) and certain of its officers and directors violated federal securities laws.

On November 26, 2018, Citron Research alleged that Mallinckrodt failed to disclose an unsuccessful clinical trial result on Mallinckrodt’s blockbuster drug Acthar.

Following this news, the Company's stock fell as much as 13%.

If you have purchased or otherwise acquired Mallinckrodt securities and have questions about your legal rights, or possess information relevant to this investigation, you are encouraged to contact attorneys Dan DeMaria at (888) 868-2385, by email at dan@blockesq.com, or by visiting http://shareholder.law/mnk

Block & Leviton LLP was recently ranked 4th among securities litigation firms by ISS for recoveries in 2017. The firm represents many of the nation's largest institutional investors and numerous individual investors in securities litigation throughout the country. Indeed, its lawyers have recovered billions of dollars for its clients.

Contact us to learn more about this lawsuit.

Block & Leviton LLP
155 Federal Street, Suite 400
Boston, MA 02110
  • Mon 9am - 6pm
  • Tues 9am - 6pm
  • Wed 9am - 6pm
  • Thurs 9am - 6pm
  • Fri 9am - 6pm
  • Sat Closed
  • Sun Closed
Powered by RooSites